1-6 of 6
Francois Lefrere, Sr.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Impact of Cytogenetic Clonality on Outcomes in Younger Acute Myeloid Leukemia Patients: Results on 1290 Patients Included in the EORTC/Gimema AML-10 and AML-12 Trials

Frederic Baron, Marian Stevens-Kroef, PhD, Michal Kicinski, Giovanna Meloni, Petra Muus, Jean-Pierre Marie, Constantijn J.M. Halkes, Xavier Thomas, MD, Radovan Vrhovac, MD PhD, Crescenza Pasciolla, Francois Lefrere, Sr., Simona Sica, Marco Mancini, Adriano Venditti, MD, Anne Hagemeijer, Heiko Becker, Joop H. Jansen, Sergio Amadori, MD, T. M. M de Witte, MD PhD, Roelof Willemze, Stefan Suciu
Journal: Blood
Blood (2017) 130 (Supplement 1): 1385.
https://doi.org/10.1182/blood.V130.Suppl_1.1385.1385
Published: 2017
Journal Articles

Impact of the Type of Anthracycline and of Allogeneic Stem Cell Transplantation in the Treatment of Younger Acute Myeloid Leukemia Patients: Long-Term Follow-up of the EORTC-Gimema AML-10 Trial

Frederic Baron, Fabio Efficace, PhD, Laura Cannella, Franco Mandelli, Petra Muus, Silvia Maria Trisolini, Constantijn J.M. Halkes, Paola Fazi, Marco Vignetti, Jean-Pierre Marie, Patrizia Chiusolo, Walter JFM Van Der Velden, Edoardo La Sala, Umberto Vitolo, Xavier Thomas, MD, Francois Lefrere, Sr., Francesco Di Raimondo, MD, Jean-Henri Bourhis, Giorgina Specchia, Jose E. Guimaraes, MD PhD, Bernardino Allione, Radovan Vrhovac, MD PhD, Felicetto Ferrara, Marian Stevens-Kroef, PhD, Roelof Willemze, Sergio Amadori, MD, Theo de Witte, Stefan Suciu
Journal: Blood
Blood (2017) 130 (Supplement 1): 3850.
https://doi.org/10.1182/blood.V130.Suppl_1.3850.3850
Published: 2017
Journal Articles

Longer Term Follow-up on the First Patients with Severe Hemoglobinopathies Treated with Lentiglobin Gene Therapy

Marina Cavazzana, MD PhD, Salima Hacein-Bey-Abina, Pharm.D.,PhD, Emmanuel Payen, Elisa Magrin, PhD, Alessandra Magnani, MD PhD, Michaela Semeraro, Laure Caccavelli, Fabien Touzot, MD PhD, Francois Lefrere, Sr., Felipe Suarez, MDPhD, Olivier Hermine, Valentine Brousse, MD, Catherine Poirot, Despina Moshous, Philippe Bourget, PhD, Wassim El Nemer, PhD, Pablo Bartolucci, MD PhD, Leslie Weber, Herve Puy, MD, Jean-François Meritet, David Grévent, MD, Yves Beuzard, MD, Stany Chretien, Thibaud Lefebvre, Mohammed Asmal, MD PhD, Alexandra Laura Miller, Mariane De Montalembert, MD PhD, Stephane Blanche, MD, Philippe Leboulch, MD, Jean-Antoine Ribeil, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4609.
https://doi.org/10.1182/blood.V130.Suppl_1.4609.4609
Published: 2017
Journal Articles

Impact of Induction Regimen and of Allogeneic Hematopoietic Cell Transplantation on the Outcome in Younger Adults Patients with Acute Myeloid Leukemia with a Monosomal Karyotype: Results from the EORTC/Gimema AML-10 and AML-12 Trials

Frederic Baron, MD PhD, Marian Stevens-Kroef, PhD, Giovanna Meloni, MD, Petra Muus, MD PhD, Jean-Pierre Marie, MD, Constantijn J.M. Halkes, MD PhD, Xavier Thomas, MD PhD, Radovan Vrhovac, MD PhD, Giorgina Specchia, MD, Francois Lefrere, Sr., MD, Simona Sica, Marco Mancini, MD, Adriano Venditti, MD, Anne Hagemeijer, MD, Joop H. Jansen, PhD, Sergio Amadori, MD, Theo de Witte, MD, Roelof Willemze, MD PhD, Stefan Suciu, PhD
Journal: Blood
Blood (2016) 128 (22): 2847.
https://doi.org/10.1182/blood.V128.22.2847.2847
Published: 2016
Journal Articles

Impact of Rituximab on Peripheral Blood Stem Cell Mobilization and Collection Following ACVBP Regimen in Poor Risk Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results from a Large Cohort of Patients from Two Prospective GELA Trials.

Francois Lefrere, Sr., MD, Dominique bastit-Barrau, MD, Suzanne Mathieu, MD, Alain Bohbot, MD, Philippe Bourrin, MD, Gilles Andre Salles, MD, PhD, Herve Tilly, MD, Nicolas Mounier, MD, Olivier Fitoussi, MD, Corinne Haioun
Journal: Blood
Blood (2008) 112 (11): 2314.
https://doi.org/10.1182/blood.V112.11.2314.2314
Published: 2008
Journal Articles

High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SDAraC) during Induction and Value of IL-2 during Maintenance in Acute Myelogenous Leukemia (AML): Impact of AraC Dose on Complete Remission Rate and Toxicity (Results on the first 1700 randomized patients of the AML-12 trial of EORTC and GIMEMA Leukemia Groups)

Roelof Willemze, MD, PhD, Stefan Suciu, Franco Mandelli, Boris Labar, MD, PhD, Jean-Pierre Marie, Martin Mistrik, MD, PhD, Vincenzo Liso, Francesco Fabbiano, Francesco Nobile, Marco Sborgia, Bruno Rotoli, Dominik L.D. Selleslag, MD, Francois Lefrere, Sr., MD, Antonio Peta, Massimo F Martelli, Giuseppe Leone, Nicola Cantore, Meral Beksac, Zwi Berneman, Xavier Thomas, Michele Mario Greco, Dominique Bron, Georges Fillet, Jose E. Guimaraes, MD, PhD, Petra Muus, Paola Fazi, Liliana Baila, Marco Vignetti, Sergio Amadori, Theo de Witte on behalfhe European Group for Blood Marrow Transplantation, Giovanna Meloni
Journal: Blood
Blood (2008) 112 (11): 134.
https://doi.org/10.1182/blood.V112.11.134.134
Published: 2008